MIC B Complex Injectable from Talon Compounding Pharmacy Recalled for Sterility Concerns
Talon Compounding Pharmacy is recalling MIC B Complex INJ-MILES FORMULATION INJECTABLE due to lack of assurance of sterility. The drug is distributed across the United States, including Washington, D.C. and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable product with a potential for serious harm. The source text does not report any illnesses or injuries, but the hazard—loss of sterility assurance in an injectable—presents a high risk of serious health consequences (infection, sepsis, septic shock) if administered. Per the rubric, high-risk pathogens or risk-of-harm products where injury has not yet been reported score 3.
Plain-English summary
Vita Pharmacy, LLC, doing business as Talon Compounding Pharmacy, located in San Antonio, Texas, is recalling MIC B COMPLEX INJ-MILES FORMULATION INJECTABLE (Rx only) due to lack of assurance of sterility.
The recalled product was distributed throughout the United States, including Washington, D.C. and Puerto Rico. The affected lot is 08112021:46 with a Beyond Use Date (BUD) of 11/09/2021.
Sterility assurance is critical for injectable products because non-sterile injections can introduce bacterial or other microbial contamination directly into the body. Consumers who have received this product should consult their healthcare provider if they have concerns about their treatment or health status.
Anyone with questions about this recall should contact Talon Compounding Pharmacy at the address listed in San Antonio, Texas.
The recalled product
- Product
- MIC B COMPLEX INJ-MILES FORMULATION INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Injectable / Compounded
- Hazard
- sterility-assurance
- microbial-contamination
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 08112021:46 BUD: 11/09/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27